Summarily, dioscin ameliorates myocardial ischemia/reperfusion injury through suppressing reactive oxygen species via downregulation of Nox2 and upregulation of the antioxidative enzyme, including SOD, CAT, GPx, and GSH, leading to alleviate cardiac dysfunction. This evidence concerns the gene CYBB and myocardial ischemia.